Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers

Eiichi Watanabe, Haruhiko Abe, Shigeyuki Watanabe

Research output: Contribution to journalReview article

7 Citations (Scopus)


Implantable cardioverter-defibrillators (ICDs) improve the survival in patients at risk of sudden cardiac death. However, these patients have an ongoing risk of sudden incapacitation that may cause harm to individuals and others when driving. Considerable disagreement exists about whether and when these patients should be allowed to resume driving after ICD therapies. This information is critical for the management decisions to avoid future potentially lethal incidents and unnecessary restrictions for ICD patients. The cardiac implantable device committee of the Japanese Heart Rhythm Society reassessed the risk of driving for ICD patients based on the literature and domestic data. We reviewed the driving restrictions of ICD patients in various regions and here present updated Japanese driving restrictions.

Original languageEnglish
Pages (from-to)594-601
Number of pages8
Journaljournal of arrhythmia
Issue number6
Publication statusPublished - 12-2017


All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this